Optimizing Treatment Strategies For Leukemia in JAPAC – 29th September 2022

AbbVie Sdn Bhd in collaboration with MSH invites you......

  • Event description:

To continue advancing leukaemia care in JAPAC, we have invited renowned international speakers, Dr. Othman Al-Sawaf (University Hospital of Cologne, Germany) to discuss the latest updates in CLL management and Dr. Daniel Pollyea (University of Colorado, USA) to discuss about how to maximise the treatment response in newly diagnosed high-risk AML who ineligible for intensive chemotherapy. We also invited A/Prof Hisayuki Yokoyama to share a case on management approaches in MDS transformed secondary AML. For RSVP: https://event.on24.com/wcc/r/3844200/ADB3245E8586538C1E6E1BF66278819E